Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2014, Article ID 254683, 8 pages
http://dx.doi.org/10.1155/2014/254683
Research Article

Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy

1Department of Physiology, Faculty of Medicine, Cairo University, Giza 11562, Egypt
2Department of Biochemistry, Faculty of Medicine, Cairo University, Giza 11562, Egypt
3Department of Anesthesia, Pain Management and Perioperative Medicine, Faculty of Medicine, Dalhousie University, 5850 College Street, Halifax, NS, Canada B3H 2Y9

Received 7 October 2013; Revised 8 December 2013; Accepted 26 December 2013; Published 17 February 2014

Academic Editor: Di Lazzaro Vincenzo

Copyright © 2014 Maha Gamal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Detry, A. de Roover, P. Honoré, and M. Meurisse, “Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management,” World Journal of Gastroenterology, vol. 12, no. 46, pp. 7405–7412, 2006. View at Google Scholar · View at Scopus
  2. S. C. Tauber and R. Nau, “Immunomodulatory properties of antibiotics,” Current Molecular Pharmacology, vol. 1, no. 1, pp. 68–79, 2008. View at Google Scholar · View at Scopus
  3. H. Macdonald, R. G. Kelly, E. S. Allen, J. F. Noble, and L. A. Kanegis, “Pharmacokinetic studies on minocycline in man,” Clinical Pharmacology and Therapeutics, vol. 14, no. 5, pp. 852–861, 1973. View at Google Scholar
  4. R. F. Butterworth, “Hepatic encephalopathy: a central neuroinflammatory disorder?” Hepatology, vol. 53, no. 4, pp. 1372–1376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Heiss, E. Papavassiliou, M. J. Merrill et al., “Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats: involvement of the glucocorticoid receptor and vascular permeability factor,” Journal of Clinical Investigation, vol. 98, no. 6, pp. 1400–1408, 1996. View at Google Scholar · View at Scopus
  6. M. R. Machein, J. Kullmer, V. Rönicke et al., “Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells,” Neuropathology and Applied Neurobiology, vol. 25, no. 2, pp. 104–112, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Rocksén, B. Lilliehöök, R. Larsson, T. Johansson, and A. Bucht, “Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation,” Clinical and Experimental Immunology, vol. 122, no. 2, pp. 249–256, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Keegan-Rogers and G. Y. Wu, “Targeted protection of hepatocytes from galactosamine toxicity in vivo,” Cancer Chemotherapy and Pharmacology, vol. 26, no. 2, pp. 93–96, 1990. View at Google Scholar · View at Scopus
  9. T. Nakamura, G. Xi, Y. Hua, T. Schallert, J. T. Hoff, and R. F. Keep, “Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 5, pp. 487–494, 2004. View at Google Scholar · View at Scopus
  10. D. E. Tupper and R. B. Wallace, “Utility of the neurological examination in rats,” Acta Neurobiologiae Experimentalis, vol. 40, no. 6, pp. 999–1003, 1980. View at Google Scholar · View at Scopus
  11. J. Polson and W. M. Lee, “AASLD position paper: the management of acute liver failure,” Hepatology, vol. 41, no. 5, pp. 1179–1197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H. Hoofnagle, R. L. Carithers Jr., C. Shapiro, and N. Ascher, “Fulminant hepatic failure: summary of a workshop,” Hepatology, vol. 21, no. 1, pp. 240–252, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Nicolao, C. Efrati, A. Masini, M. Merli, A. F. Attili, and O. Riggio, “Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy,” Journal of Hepatology, vol. 38, no. 4, pp. 441–446, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Plauth, A.-E. Roske, P. Romaniuk, E. Roth, R. Ziebig, and H. Lochs, “Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration,” Gut, vol. 46, no. 6, pp. 849–855, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. O. Riggio, C. Efrati, C. Catalano et al., “High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study,” Hepatology, vol. 42, no. 5, pp. 1158–1165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Kramer, B. Tribl, A. Gendo et al., “Partial pressure of ammonia versus ammonia in hepatic encephalopathy,” Hepatology, vol. 31, no. 1, pp. 30–34, 2000. View at Google Scholar · View at Scopus
  17. D. D. Mousseau and R. F. Butterworth, “Current theories on the pathogenesis of hepatic encephalopathy,” Proceedings of the Society for Experimental Biology and Medicine, vol. 206, no. 4, pp. 329–344, 1994. View at Google Scholar · View at Scopus
  18. E. Kosenko, Y. Kaminsky, A. Kaminsky et al., “Superoxide production and antioxidant enzymes in ammonia intoxication in rats,” Free Radical Research, vol. 27, no. 6, pp. 637–644, 1997. View at Google Scholar · View at Scopus
  19. E. Kosenko, N. Venediktova, Y. Kaminsky, C. Montoliu, and V. Felipo, “Sources of oxygen radicals in brain in acute ammonia intoxication in vivo,” Brain Research, vol. 981, no. 1-2, pp. 193–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. D. P. Stirling, K. M. Koochesfahani, J. D. Steeves, and W. Tetzlaff, “Minocycline as a neuroprotective agent,” Neuroscientist, vol. 11, no. 4, pp. 308–322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. S. Kim and Y. H. Suh, “Minocycline and neurodegenerative diseases,” Behavioural Brain Research, vol. 196, no. 2, pp. 168–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. D. Norenberg, K. V. Rama Rao, and A. R. Jayakumar, “Signaling factors in the mechanism of ammonia neurotoxicity,” Metabolic Brain Disease, vol. 24, no. 1, pp. 103–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. V. Rama Rao, A. R. Jayakumar, X. Tong, V. M. Alvarez, and M. D. Norenberg, “Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes,” Journal of Neuroinflammation, vol. 7, article 66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Vaquero, C. Chung, and A. T. Blei, “Cerebral blood flow in acute liver failure: a finding in search of a mechanism,” Metabolic Brain Disease, vol. 19, no. 3-4, pp. 177–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Jiang, P. Desjardins, and R. F. Butterworth, “Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline,” Journal of Neurochemistry, vol. 109, no. 2, pp. 485–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Jiang, P. Desjardins, and R. F. Butterworth, “Minocycline attenuates oxidative/nitrosative stress and cerebral complications of acute liver failure in rats,” Neurochemistry International, vol. 55, no. 7, pp. 601–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. M. Sapolsky, L. M. Romero, and A. U. Munck, “How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions,” Endocrine Reviews, vol. 21, no. 1, pp. 55–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. C. L. Raison and A. H. Miller, “When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders,” The American Journal of Psychiatry, vol. 160, no. 9, pp. 1554–1565, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Seven, M. Aslan, S. Incir, and A. Altintas, “Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy,” Folia Neuropathologica, vol. 51, no. 1, pp. 58–64, 2013. View at Google Scholar
  30. M. A. Lozovoy, A. N. Simão, C. Panis et al., “Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus,” Lupus, vol. 20, no. 12, pp. 1250–1259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. C. Tsai, S. C. Kao, C. Y. Cheng et al., “Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy,” Archives of Ophthalmology, vol. 125, no. 12, pp. 1652–1656, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Rajashree and R. Puvanakrishnan, “Dexamethasone induced alterations in enzymatic and nonenzymatic antioxidant status in heart and kidney of rats,” Molecular and Cellular Biochemistry, vol. 181, no. 1-2, pp. 77–85, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Gokce, O. Saydam, V. Hanci, M. Can, and B. Bahadir, “Antioxidant vitamins C, E and coenzyme Q10 vs dexamethasone: comparisons of their effects in pulmonary contusion model,” Journal of Cardiothoracic Surgery, vol. 7, article 92, 2012. View at Publisher · View at Google Scholar
  34. L. Frank, P. L. Lewis, and I. R. S. Sosenko, “Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation,” Pediatrics, vol. 75, no. 3, pp. 569–574, 1985. View at Google Scholar · View at Scopus
  35. H. J. José, S. G. Berenice, and V. R. Cecilia, “Induction of antioxidant enzymes by dexamethasone in the adult rat lung,” Life Sciences, vol. 60, no. 23, pp. 2059–2067, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Canalese, A. E. Gimson, and C. Davis, “Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure,” Gut, vol. 23, no. 7, pp. 625–629, 1982. View at Google Scholar · View at Scopus
  37. W. G. Bradley, Neurology in Clinical Practice, Butterworth-Heinemann, Boston, Mass, USA, 3rd edition, 2000.
  38. L. Spahr, “Brain oedema and acute liver failure,” Annales Françaises d'Anesthésie et de Réanimation, vol. 22, no. 4, pp. 325–330, 2003. View at Publisher · View at Google Scholar
  39. M. D. Josephs, F. R. Bahjat, K. Fukuzuka et al., “Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-α and not by Fas ligand,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 278, no. 5, pp. R1196–R1201, 2000. View at Google Scholar · View at Scopus
  40. R. A. Lawrenson, H. E. Seaman, A. Sundström, T. J. Williams, and R. D. T. Farmer, “Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data,” Drug Safety, vol. 23, no. 4, pp. 333–349, 2000. View at Google Scholar · View at Scopus
  41. H. E. Seaman, R. A. Lawrenson, T. J. Williams, K. D. MacRae, and R. D. Farmer, “The risk of liver damage associated with minocycline: a comparative study,” Journal of Clinical Pharmacology, vol. 41, no. 8, pp. 852–860, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. D. Wei, J. Z. Li, Z. J. Liu et al., “Dexamethasone attenuates lipopolysaccharide-induced liver injury by downregulating glucocorticoid-induced tumor necrosis factor receptor ligand in Kupffer cells,” Hepatology Research, vol. 41, no. 10, pp. 989–999, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. A. A. Boulton, G. B. Baker, and R. F. Butterworth, Animal Models of Neurological Disease, Humana Press, Totowa, NJ, USA, 1992.
  44. D. F. Schafer, S. C. Pappas, and L. E. Brody, “Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas,” Gastroenterology, vol. 86, no. 3, pp. 540–545, 1984. View at Google Scholar · View at Scopus